A new Cluster publication from the lab of Principal Investigator Daniela Duarte Campos, featuring the work of Cluster Doctoral Researcher Alexandre Taoum and Mario Wisbar, Cluster Postdoctoral Researcher Freiderike Dehli, as well as Cluster Alumnus Ole Thaden, demonstrates that human-derived low-serum FBS alternatives can support the maintenance and differentiation of stromal cell phenotypes.
The use of animal-free serum alternatives represents an important step toward clinically relevant systems. The authors demonstrate that human-derived serum alternatives are worth exploring in corneal bioprinting and regenerative ophthalmology.
© Taoum, A., Oster, J.S., Thaden, O. et al., Sci Rep 16, 18874 (2026), CC BY 4.0